The other group at the highest risk when it comes to RSV is children under age five, and specifically infants—especially ...

The CDC recommends a single dose of any FDA-approved respiratory syncytial virus (RSV) vaccine for all adults ages 75 years ...

Regarding hospitalizations among immunocompetent older adults, vaccine effectiveness was 83% for the GSK vaccine and 73% for ...

Current guidelines recommend that pregnant people receive a vaccine against respiratory syncytial virus (RSV) -- which typically causes mild, cold-like symptoms in most adults but can be deadly for ...

In three months, the distribution of RSV vaccines will begin in the Americas, according to a PAHO announcement.

For adults aged 60 years or older, RSV vaccination is effective for preventing associated hospitalizations and ED encounters.

Current guidelines recommend that pregnant people receive a vaccine against respiratory syncytial virus (RSV)-;which typically causes mild, cold-like symptoms in most adults but can be deadly for ...

Infants are among the most susceptible to respiratory complications from respiratory syncytial virus, or RSV. While they can ...

The seasonal COVID-19 spike, combined with rising cases of seasonal flu and RSV, brings what has been called a “tripledemic.” ...

Coughing, sneezing, and high temperature are common signs of a cold. While these may look harmless, they can also be symptoms ...

That’s the most prevalent right now, and then we also have the RSV virus, which is about 20.9%,” Dr. Khan explained that seasonal viruses are beginning to tick up again. RSV is a virus that ...

The world's first bivalent mRNA vaccine candidate against respiratory syncytial virus, or RSV, kicked off Phase I clinical ...